Denis Glotz

Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period.

Journal: Journal of nephrology

Published: March 17, 2025

Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: October 04, 2024

The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis.

Journal: Frontiers in immunology

Published: December 21, 2023

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.

Journal: Clinical transplantation

Published: August 03, 2022

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME).

Journal: BMJ open

Published: March 30, 2022

Improving equity in kidney transplant allocation policies through a novel genetic metric: The Matched Donor Potential.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 29, 2022

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.

Journal: Clinical transplantation

Published: December 23, 2021

Surrogate Endpoints for Late Kidney Transplantation Failure.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: October 21, 2021

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: October 21, 2021

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: October 21, 2021

Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period.

Immunosuppressive treatment patterns in kidney transplant recipients in France: an insurance claims database study (OISTER) over a 12 year period.

Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus.

Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus.

The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis.

The role of donor hypertension and angiotensin II in the occurrence of early pancreas allograft thrombosis.

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME).

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME).

Improving equity in kidney transplant allocation policies through a novel genetic metric: The Matched Donor Potential.

Improving equity in kidney transplant allocation policies through a novel genetic metric: The Matched Donor Potential.

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.

Restriction of interleukin-6 alters endothelial cell immunogenicity in an allogenic environment.

Surrogate Endpoints for Late Kidney Transplantation Failure.

Surrogate Endpoints for Late Kidney Transplantation Failure.

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.

Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.

Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.

Medication adherence in renal transplantation: Evaluation, predictive factors and impact on humoral alloreactivity

Medication adherence in renal transplantation: Evaluation, predictive factors and impact on humoral alloreactivity